Cannabis: From Cultivar to Chemovar II - A Metabolomics Approach to Cannabis Classification

Cannabis and Cannabinoid Research

Volumn 1, Issue 1, 2016, Pages 202-215

  Hazekamp, Arno ^a   Tejkalová, Katerina ^b   Papadimitriou, Stelios ^b  

^a Bedrocan BV   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

cannabinoids; cannabis; gas chromatography; multivariate data analysis; terpenes; varieties

Indexed keywords

3 CARENE; ALPHA 2 PINENE; ALPHA GUAIENE; ALPHA PHELLANDRENE; AROMADENDRENE; BETA 2 PINENE; BETA EUDESMOL; BETA FENCHOL; BISABOLOL; BORNEOL; CANNABICHROMENE; CANNABIDIOL; CANNABINOID DERIVATIVE; CARYOPHYLLENE; DELTA GUAIENE; DRONABINOL; GAMMA CADINENE; GAMMA SELINENE; HUMULENE; LINALOOL; MEDICAL CANNABIS; MYRCENE; NEROLIDOL; SESQUITERPENE DERIVATIVE; TERPENE; TERPENE DERIVATIVE; TERPINENE; TERPINEOL; TERPINOLENE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; CANNABIS SATIVA; CANNABIS SATIVA SUBSP. INDICA; CHEMICAL COMPOSITION; CHEMOTAXONOMY; DRUG CLASSIFICATION; DRUG IDENTIFICATION; DRUG LEGISLATION; DRUG SCREENING; GAS CHROMATOGRAPHY; MEDICAL DECISION MAKING; METABOLOMICS; NETHERLANDS; PRIORITY JOURNAL; SCIENTIST;

EID: 85010010783     PISSN: None     EISSN: 23788763     Source Type: Journal    
DOI: 10.1089/can.2016.0017     Document Type: Article

References (51)

1. Kowal MA, Hazekamp A, Grotenhermen F. Review on clinical studies with cannabis and cannabinoids 2010-2014. Cannabinoids. 2016;11(special issue):1-18.
2. Hazekamp A, Grotenhermen F. Review on clinical studies with cannabis and cannabinoids 2005-2009. Cannabinoids. 2010;5:1-21.
3. Erkelens JL, Hazekamp A. That which we call Indica, by any other name would smell as sweet. Cannabinoids. 2014;9:9-15.
4. Monograph Cannabis flos Version 7.1. Office of Medicinal Cannabis (OMC): The Hague: The Netherlands, 2014.
5. The Advisability and Feasibility of Developing USP Standards for Medical Cannabis. Stimuli to the revision process. USP-NF (US Parmacopeia-National Formulary): Rockville, MD, 2015.
6. Upton R, Craker L, ElSohly M, et al. Cannabis Inflorescence (cannabis spp.)-standards of identity, analysis, and quality control (revision 2014). American Herbal Pharmacopoeia (AHP): Soquel, CA, 2014.
7. Small E, Cronquist A. A practical and natural taxonomy for Cannabis. Taxon. 1976;25:405-435.
8. Hazekamp A, Fischdick JT. Cannabis-from cultivar to chemovar. Drug Test Anal. 2012;4:660-667.
9. Brodie JS, Di Marzo V, Guy GW. Polypharmacology shakes hands with complex aetiopathology. Trends Pharmacol Sci. 2015;36:802-821.
10. Szaflarski JP, Bebin EM. Cannabis, cannabidiol, and epilepsy-from receptors to clinical response. Epilepsy Behav. 2014;41:277-282.
11. Crippa JA, Derenusson GN, Ferrari TB, et al. Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report. J Psychopharmacol. 2011;25:121-130.
12. Pagano E, Montanaro V, Di Girolamo A, et al. Effect of non-psychotropic plant-derived cannabinoids on bladder contractility: focus on cannabigerol. Nat Prod Commun. 2015;10:1009-1012.
13. Borrelli F, Pagano E, Romano B, et al. Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived nonpsychotropic cannabinoid. Carcinogenesis. 2014;35:2787-2797.
14. Englund A, Atakan Z, Kralj A, et al. The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: a placebo-controlled, double-blind, crossover pilot trial. J Psychopharmacol. 2016;30:140-151.
15. Tudge L, Williams C, Cowen PJ, et al. Neural effects of cannabinoid CB1 neutral antagonist tetrahydrocannabivarin on food reward and aversion in healthy volunteers. Int J Neuropsychopharmacol. 2014;18:pii: pyu094.
16. Russo EB. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011; 163:1344-1364.
17. Hazekamp A, Fischedick JT, Diez ML, Lubbe A, Ruhaak RL. Chemistry of Cannabis. In: Mander L, Lui H-W (eds.). Comprehensive Natural Products II Chemistry and Biology (vol. 3). Elsevier: Oxford, UK, 2010, pp. 1033-1084.
18. Brenneisen R, ElSohly MA. Chromatographic and spectroscopic profiles of cannabis of different origins: Part I. J Forens Sci. 1988;33:1385-1404.
19. Bakel H van, Stout JM, Cote AG, et al. The draft genome and transcriptome of Cannabis sativa. Genome Biol. 2011;12:R102.
20. Lynch RL, Vergara D, Tittes S, et al. Genomic and Chemical Diversity in Cannabis. BioRxiv. 2015.
21. Sawler J, Stout JM, Gardner KM, et al. The genetic structure of marijuana and hemp. PLoS One. 2015;10:e0133292.
22. Pearce DD, Mitsouras K, Irizarry KJ. Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users. J Alt Comp Med. 2014;20:787-791.
23. Hazekamp A, Pappas G. Self-medication with Cannabis. In: Handbook of Cannabis. Oxford University Press: Oxford, UK, 2014.
24. Elzinga S, Fischedick J, Podkolinski R, et al. Cannabinoids and terpenes as chemotaxonomic markers in Cannabis. Nat Prod Chem Res. 2015;3:181.
25. Hillig KW. Genetic evidence for speciation in Cannabis (cannabaceae). Genet Resour Crop Evol. 2005;52:161-180.
26. McPartland J, Guy G. Correct(ed) vernacular nomenclature of Cannabis. O'Shaugnessy's online journal. Edition 4, January 2015.
27. Fischedick JT, Hazekamp A, Erkelens T, et al. Metabolic fingerprinting of Cannabis sativa L., cannabinoids and terpenoids for chemotaxonomic and drug standardization purposes. Phytochemistry. 2010;71:2058-2073.
28. Hazekamp A, Simons R, Peltenburg-Looman A, et al. Preparative isolation of cannabinoids from Cannabis sativa by centrifugal partition chromatography. J Liq Chrom Rel Technol. 2004;27:2421-2439.
29. Hazekamp A, Choi YH, Verpoorte R. Quantitative analysis of cannabinoids from Cannabis sativa using 1H-NMR. Chem Pharm Bull. 2004;52:718-721.
30. Coffeeshops in Nederland 2014 [Coffeeshops in the Netherlands 2014]. Bureau Intraval: Groningen-Rotterdam, The Netherlands, 2015.
31. Komori T, Nohara T, Hosokawa I, et al. Cannabigerol monomethyl ether, a new component of hemp. Chem Pharm Bull. 1968;16:1164-1165.
32. Adams RP. Identification of essential oils by ion trap mass spectrometry. Academic Press Inc.: New York, 1989.
33. Ross SA, ElSohly MA. The volatile oil composition of fresh and air-dried buds of Cannabis sativa. J Nat Prod. 1996;59:49-51.
34. Hillig KW. A chemotaxonomic analysis of terpenoid variation in cannabis. Biochem Syst Ecol. 2004;32:875-891.
35. Hillig KW, Mahlberg PG. A chemotaxonomic analysis of cannabinoid variation in cannabis (cannabaceae). Am J Bot. 2004;91:966-975.
36. Rothschild M, Bergström G, Wångberg S. Cannabis sativa: volatile compounds from pollen and entire male and female plants of two variants, Northern lights and Hawaian indica. Bot J Linnean Soc. 2005;147:387-397.
37. Jolliffe IT, Cadima J. Principal component analysis: a review and recent developments. Philos Trans A Math Phys Eng Sci. 2016;374:20150202.
38. Eriksson L, Johansson E, Kettaneh-Wold N, et al. Multi-and megavariate data analysis part 1: basic principles and applications, second edition. Umetrics Ltd.: Umeå, Sweden, 2006.
39. Trygg J, Wold S. Orthogonal projections to latent structures (O-PLS). J Chemometr. 2002;16:119-128.
40. Barshan E, Ghodsi A, Azimifar Z, et al. Supervised principal component analysis: visualization, classification and regression on subspaces and submanifolds. Pattern Recognit. 2011;44:1357-1371.
41. Brenneisen R, Kessler T. Psychotrope Drogen. V. Die Variabilitat der Cannabinoidfuhrung von Cannabispflanzen aus Schweizer Kulturen in Abhängigkeit von genetischen und ökologischen Faktoren [Psychotropic drugs. V. Variability of cannabinoid liberation from Cannabis plants grown in Switzerland in relation to genetic and ecological factors]. Pharm Acta Helv. 1987;62:134-139.
42. National Drug Monitor, annual report 2015. Trimbos Institute: Utrecht, The Netherlands, 2015.
43. Mansouri H, Asrar Z, Amarowicz R. The response of terpenoids to exogenous gibberellic acid in Cannabis sativa L. at vegetative stage. Acta Physiologiae Plantarum. 2011;33:1085-1091.
44. Chailakhyan MK, Khryanin VN. The influence of growth regulators absorbed by the root on sex expression in hemp plants. Planta. 1978;138:181-184.
45. Heslop-Harrison J, Heslop-Harrison Y. Studies on flowering-plant growth and organogenesis: IV. Effects of gibberellic acid on flowering and the secondary sexual difference in stature in Cannabis sativa. Proc Roy Irish Acad., Sect B. 1960/1961;61:219-232.
46. Rosenthal E, Chong T. Marijuana grower's handbook: your complete guide for medical and personal marijuana cultivation. Quick American Archives: San Francisco, CA, 2010.
47. Janocha S, Schmitz D, Bernhardt R. Terpene hydroxylation with microbial cytochrome P450 monooxygenases. Adv Biochem Eng Biotechnol. 2015; 148:215-250.
48. Takahashi S, Yeo Y, Greenhagen BT, et al. Metabolic engineering of sesquiterpene metabolism in yeast. Biotechnol Bioeng. 2007;97: 170-181.
49. Turner CE, Elsohly MA, Boeren EG. Constituents of Cannabis sativa L. XVII. A review of the natural constituents. J Nat Prod. 1980;43:169-234.
50. Aizpurua-Olaizola O, Soydaner U, Öztürk E, et al. Evolution of the cannabinoid and terpene content during the growth of Cannabis sativa plants from different chemotypes. J Nat Prod. 2016;79:324-331.
51. Piomelli D, Russo EB. The Cannabis sativa versus Cannabis indica debate: an interview with Ethan Russo, MD. Cannabis and Cannabinoid Research. 2016;1:44-46.